India’s Piramal Enterprises says it is considering selling up to a 20% minority stake in its pharmaceutical business, Piramal Healthcare, to raise money for acquisitions aimed at bulking up the business ahead of an eventual stock market listing.
The acquisition plan is in line with the leading conglomerate's long-term plan to demerge its pharmaceutical and financial services businesses...




